Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-28

FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a generic fixed-dose combination of tri­amterene and hydrochlorothiazide from Macleods Pharmaceuticals Limited under an original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamterene and Hydrochlorothiazide (Triamterene and hydrochlorothiazide)

Snippet

ORIG AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)